Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
European Journal of Heart Failure
|
September 25, 2025
Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey
Petar M Seferović, Marija Polovina, Jan Krejči, et al.
European Journal of Preventive Cardiology
|
February 13, 2021
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K Ray, Bart Molemans, W Marieke Schoonen, et al.
European Journal of Preventive Cardiology
|
February 18, 2015
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Kornelia Kotseva, David Wood, Dirk De Bacquer, et al.
Cardiovascular Drugs and Therapy
|
May 14, 2022
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
Antonio J Vallejo-Vaz, Sarah Bray, Guillermo Villa, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era
Marco Ambrosetti, Ana Abreu, Veronique Cornelissen, et al.
Cardiovascular Diabetology
|
October 3, 2015
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
Viveca Gyberg, Dirk De Bacquer, Guy De Backer, et al.
European Journal of Epidemiology
|
October 25, 2018
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study
Dirk De Bacquer, Delphine De Smedt, Kornelia Kotseva, et al.
Drugs
|
November 4, 2024
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Željko Reiner, Stanisław Surma, et al.
European Journal of Preventive Cardiology
|
February 12, 2019
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
Kornelia Kotseva, Guy De Backer, Dirk De Bacquer, et al.
Journal of Hypertension
|
June 15, 2007
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Giuseppe Mancia, Guy De Backer, Anna Dominiczak, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
European Journal of Heart Failure
|
September 25, 2025
Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey
Petar M Seferović, Marija Polovina, Jan Krejči, et al.
European Journal of Preventive Cardiology
|
February 13, 2021
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
Kausik K Ray, Bart Molemans, W Marieke Schoonen, et al.
European Journal of Preventive Cardiology
|
February 18, 2015
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Kornelia Kotseva, David Wood, Dirk De Bacquer, et al.
Cardiovascular Drugs and Therapy
|
May 14, 2022
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
Antonio J Vallejo-Vaz, Sarah Bray, Guillermo Villa, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era
Marco Ambrosetti, Ana Abreu, Veronique Cornelissen, et al.
Cardiovascular Diabetology
|
October 3, 2015
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
Viveca Gyberg, Dirk De Bacquer, Guy De Backer, et al.
European Journal of Epidemiology
|
October 25, 2018
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study
Dirk De Bacquer, Delphine De Smedt, Kornelia Kotseva, et al.
Drugs
|
November 4, 2024
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)
Maciej Banach, Željko Reiner, Stanisław Surma, et al.
European Journal of Preventive Cardiology
|
February 12, 2019
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry
Kornelia Kotseva, Guy De Backer, Dirk De Bacquer, et al.
Journal of Hypertension
|
June 15, 2007
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Giuseppe Mancia, Guy De Backer, Anna Dominiczak, et al.
Page
of 7